Listar por autor "Grigoriadis, N."
Mostrando ítems 1-7 de 7
-
Characterization of In Vitro Expanded Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Experimental Autoimmune Encephalomyelitis Mice
Zacharaki, D.; Lagoudaki, R.; Touloumi, O.; Kotta, K.; Voultsiadou, A.; Poulatsidou, K. N.; Lourbopoulos, A.; Hadjigeorgiou, G.; Dardiotis, E.; Karacostas, D.; Grigoriadis, N. (2013)Extensive experimental studies indicate that autologous bone marrow mesenchymal stem cells (BMSCs) are able to ameliorate experimental autoimmune encephalomyelitis (EAE) and potentially multiple sclerosis. However, the ... -
Connexin43 and Connexin47 Alterations after Neural Precursor Cells Transplantation in Experimental Autoimmune Encephalomyelitis
Theotokis, P.; Kleopa, K. A.; Touloumi, O.; Lagoudaki, R.; Lourbopoulos, A.; Nousiopoulou, E.; Kesidou, E.; Poulatsidou, K. N.; Dardiotis, E.; Hadjigeorgiou, G.; Karacostas, D.; Cifuentes-Diaz, C.; Irinopoulou, T.; Grigoriadis, N. (2015)Exogenous transplanted neural precursor cells (NPCs) exhibit miscellaneous immune-modulatory effects in models of autoimmune demyelination. However, the regional interactions of NPCs with the host brain tissue in remissive ... -
The economic and humanistic burden of multiple sclerosis: results from the STORMS study in Greece
Yfantopoulos, J.; Grigoriadis, N.; Hadjigeorgiou, G.; Iliopoulos, I.; Karageorgiou, K.; Kyritsis, A. P.; Papathanasopoulos, P.; Chantzikou, M.; Georgiopoulos, D.; Vikelis, M. (2013) -
The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
Tsivgoulis, G.; Katsanos, A. H.; Grigoriadis, N.; Hadjigeorgiou, G. M.; Heliopoulos, I.; Kilidireas, C.; Voumvourakis, K. (2015)Background The aim of the present meta-analysis was to evaluate the effect of disease-modifying drugs (DMD) on brain atrophy in patients with relapsing-remitting multiple sclerosis (RRMS) using available randomized-controlled ... -
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis
Hadjigeorgiou, G. M.; Doxani, C.; Miligkos, M.; Ziakas, P.; Bakalos, G.; Papadimitriou, D.; Mprotsis, T.; Grigoriadis, N.; Zintzaras, E. (2013)What is known and objectiveThe relative effectiveness and safety profile of the treatments with marketing authorization for relapsing multiple sclerosis (MS) are not well known because randomized controlled trials with ... -
Nogo-A mRNA expression in the central nervous system of C57BL/6 mouse
Theotokis, P.; Lourbopoulos, A.; Salta, E.; Lagoudaki, R.; Polyzoidou, E.; Ravanidis, S.; Tascos, N.; Markoulatos, P.; Balatsos, N.; Grigoriadis, N. (2010) -
Virus-mediated autoimmunity in multiple sclerosis
Grigoriadis, N.; Hadjigeorgiou, G. M. (2006)Epidemiological data suggest the notion that in Multiple Sclerosis (MS) is an acquired autoimmune disease and the cause may be an environmental factor(s), probably infectious, in genetically susceptible individuals. Several ...